A method for the quantitation of protamine in plasma

Area of Science:

• Biochemistry
• Clinical Chemistry
• Analytical Chemistry

Background:

• Protamine is a critical antagonist to heparin, used clinically for heparin reversal.
• Accurate quantitation of plasma protamine levels is essential for safe and effective heparin reversal.
• Existing methods for protamine quantitation may lack specificity or simplicity.

Purpose of the Study:

• To develop and validate a novel, simple colorimetric method for plasma protamine quantitation.
• To assess the specificity and accuracy of the new method compared to conventional assays.
• To explore the potential clinical applications of the developed assay.

Main Methods:

• A colorimetric assay utilizing a competitive binding displacement mechanism between protamine and a heparin-azure A dye complex.
• Measurement of the metachromatic color change of azure A dye influenced by heparin presence.
• Comparison of plasma protamine levels with results from the Lowry protein assay.

Main Results:

• The developed method demonstrates high specificity for protamine due to its role as a heparin antagonist.
• Plasma protamine levels determined by the new method showed 94% accuracy compared to the Lowry assay.
• The assay measures protamine excess after heparin neutralization, indicating its utility in monitoring heparin reversal.

Conclusions:

• A unique and simple colorimetric method for plasma protamine quantitation has been successfully developed.
• The assay's specificity and accuracy make it a valuable tool for clinical applications, including monitoring protamine excess during heparin reversal.
• This method may also aid in elucidating the mechanisms behind heparin rebound.